TickerFacts.

Aligos Therapeutics, Inc. (ALGS): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$80.87M
Year ended 2024-12-31
2019-12-31: -$49.55M2020-12-31: -$76.33M2021-12-31: -$116.55M2022-12-31: -$80.33M2023-12-31: -$79.02M2024-12-31: -$80.87M-$80.87M
2019-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$80.87Mn/m2026-03-05, From 2024-01-01
2023-12-31-$79.02Mn/m2025-03-10, From 2023-01-01
2022-12-31-$80.33Mn/m2024-03-12, From 2022-01-01
2021-12-31-$116.55Mn/m2023-03-09, From 2021-01-01
2020-12-31-$76.33Mn/m2022-03-10, From 2020-01-01
2019-12-31-$49.55Mn/a2021-03-23, From 2019-01-01